Paeds SAQs · rheumatology-musculoskeletal-and-sports
Performance-enhancing substances in young athletes — formative SAQs
Formative SAQs on performance-enhancing substances in the young athlete: the WADA prohibited list and strict liability, the physical signs and confidential history that reveal anabolic-androgenic steroid use, the cardiovascular growth and psychiatric harms including the suicidal withdrawal, and the counselling-first management with the ATLAS prevention model.
On this page
Study tools
Target exams
SAQ 1 — The boy who gained nine kilograms (10 marks)
Stem: A fifteen-year-old boy presents with a sore shoulder. Alone in the consultation, he discloses that he has gained nine kilograms of lean mass over a term and has been injecting testosterone and an oral steroid bought online for four months. On examination he has severe cystic acne over his back and shoulders, gynaecomastia, and small testes for his pubertal stage. [6] [1]
a) Name the most likely class of substance and explain why the aromatisation of excess androgen is of specific concern in this adolescent. (2 marks) [4] [6]
b) List the physical stigmata that support the diagnosis and the baseline investigations you would arrange to quantify the harm. (3 marks) [6]
c) Explain why the cessation of androgens must be slow and supported, and what psychiatric risk an abrupt withdrawal carries. (3 marks) [4] [6]
d) Outline the five steps of the counselling pathway and the prevention evidence you would cite to the family. (2 marks) [5] [6]
References5ShowHide
- [1]Calfee R, Fadale P. Popular ergogenic drugs and supplements in young athletes. Pediatrics, 2006.PMID 16510635
- [4]Sagoe D, Molde H, Andreassen CS, Torsheim T, Pallesen S. The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Annals of Epidemiology, 2014.PMID 24582699
- [5]Goldberg L, Elliot D, Clarke GN, MacKinnon DP, Moe E, et al. Effects of a multidimensional anabolic steroid prevention intervention. The Adolescents Training and Learning to Avoid Steroids (ATLAS) Program. JAMA, 1996.PMID 8918852
- [6]Mulcahey MK, Schiller JR, Hulstyn MJ. Anabolic steroid use in adolescents: identification of those at risk and strategies for prevention. The Physician and Sportsmedicine, 2010.PMID 20959703
- [9]Kozhuharov VR, Ivanov K, Ivanova S. Dietary Supplements as Source of Unintentional Doping. BioMed Research International, 2022.PMID 35496041